Vascular Endothelial Growth Factor

Showing 1 posts of 1 posts found.

NICE rejects Lucentis for diabetic oedema

March 4, 2011
Sales and Marketing Lucentis, NICE, Novartis, VEGF, Vascular Endothelial Growth Factor, diabetic oedema, raibizumab

NICE’s draft guidance has not recommended Lucentis for diabetic oedema after ‘faulty analysis’ from manufacturer Novartis was found not to …

The Gateway to Local Adoption Series

Latest content